Beyond Air, Inc. (XAIR)
USD 0.24
(-0.49%)
USD 0.24
(-0.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 6.22 Million USD | 125.26% |
| 2023 | -25.56 Million USD | 66.69% |
| 2022 | -76.75 Million USD | -177.09% |
| 2021 | -27.7 Million USD | -85.24% |
| 2020 | -14.95 Million USD | -1289.0% |
| 2019 | -1.07 Million USD | -53.93% |
| 2018 | -699.41 Thousand USD | -121.16% |
| 2017 | 3.3 Million USD | 13628.1% |
| 2016 | 24.08 Thousand USD | 623.98% |
| 2015 | -4596.00 USD | -359.6% |
| 2014 | -1000.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | 6.22 Million USD | 124.36% |
| 2024 Q1 | -14.49 Million USD | 43.3% |
| 2024 Q2 | 3.61 Million USD | 124.96% |
| 2024 Q3 | 8.72 Million USD | 141.24% |
| 2024 Q4 | 6.22 Million USD | -28.63% |
| 2023 FY | -25.56 Million USD | 66.69% |
| 2023 Q2 | -26.88 Million USD | 61.31% |
| 2023 Q3 | -22.64 Million USD | 15.75% |
| 2023 Q4 | -25.56 Million USD | -12.89% |
| 2023 Q1 | -69.47 Million USD | 9.49% |
| 2022 Q2 | -41.15 Million USD | -29.35% |
| 2022 Q4 | -76.75 Million USD | 5.08% |
| 2022 FY | -76.75 Million USD | -177.09% |
| 2022 Q1 | -31.81 Million USD | -14.87% |
| 2022 Q3 | -80.86 Million USD | -96.48% |
| 2021 Q2 | -16.84 Million USD | 10.52% |
| 2021 Q3 | -17.21 Million USD | -2.2% |
| 2021 Q4 | -27.7 Million USD | -60.93% |
| 2021 FY | -27.7 Million USD | -85.24% |
| 2021 Q1 | -18.82 Million USD | -25.88% |
| 2020 Q2 | -1.57 Million USD | -539.2% |
| 2020 FY | -14.95 Million USD | -1289.0% |
| 2020 Q4 | -14.95 Million USD | -678.29% |
| 2020 Q3 | -1.92 Million USD | -22.17% |
| 2020 Q1 | -246.04 Thousand USD | 77.15% |
| 2019 Q3 | -479.7 Thousand USD | -70.11% |
| 2019 Q4 | -1.07 Million USD | -124.43% |
| 2019 Q1 | -352 Thousand USD | 49.71% |
| 2019 FY | -1.07 Million USD | -53.93% |
| 2019 Q2 | -282 Thousand USD | 19.89% |
| 2018 Q4 | -700 Thousand USD | 40.07% |
| 2018 Q3 | -1.16 Million USD | 32.17% |
| 2018 FY | -699.41 Thousand USD | -121.16% |
| 2018 Q1 | -5.16 Million USD | 25.27% |
| 2018 Q2 | -1.72 Million USD | 66.63% |
| 2017 Q2 | 27.05 Thousand USD | 12.36% |
| 2017 Q4 | -6.9 Million USD | -308.89% |
| 2017 FY | 3.3 Million USD | 13628.1% |
| 2017 Q1 | 24.08 Thousand USD | 243.73% |
| 2017 Q3 | 3.3 Million USD | 12117.75% |
| 2016 Q3 | 4467.00 USD | -98.65% |
| 2016 Q4 | 7006.00 USD | 56.84% |
| 2016 FY | 24.08 Thousand USD | 623.98% |
| 2016 Q1 | 666 Thousand USD | 0.0% |
| 2016 Q2 | 331 Thousand USD | -50.3% |
| 2015 Q3 | 435 Thousand USD | 0.0% |
| 2015 Q2 | 435 Thousand USD | 0.0% |
| 2015 FY | -4596.00 USD | -359.6% |
| 2015 Q4 | 666 Thousand USD | 53.1% |
| 2014 Q4 | 23 Thousand USD | 0.0% |
| 2014 FY | -1000.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 76.999% |
| BrainsWay Ltd. | -10.32 Million USD | 160.359% |
| Cerus Corporation | 84.35 Million USD | 92.615% |
| Envoy Medical, Inc. | -3.81 Million USD | 263.319% |
| electroCore, Inc. | -9.95 Million USD | 162.572% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 221.541% |
| IceCure Medical Ltd | -9.93 Million USD | 162.704% |
| Inogen, Inc. | -103.56 Million USD | 106.014% |
| OrthoPediatrics Corp. | -9.26 Million USD | 167.217% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 271.079% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 147.56% |
| MaxCyte, Inc. | -27.76 Million USD | 122.436% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 221.232% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1181.861% |
| Orthofix Medical Inc. | 96.44 Million USD | 93.541% |
| PAVmed Inc | 29.08 Million USD | 78.584% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 136.773% |
| RxSight, Inc. | -6.68 Million USD | 193.249% |
| Sight Sciences, Inc. | -102.71 Million USD | 106.064% |
| SI-BONE, Inc. | 5.72 Million USD | -8.88% |
| TELA Bio, Inc. | -3.94 Million USD | 257.736% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 89.133% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -1669.602% |
| Acutus Medical, Inc. | 12.27 Million USD | 49.271% |
| Talis Biomedical Corporation | -57.06 Million USD | 110.916% |
| Spectral AI, Inc. | -3.5 Million USD | 277.921% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 112.97% |
| CVRx, Inc. | -59.95 Million USD | 110.389% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -213.939% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -387.541% |
| Bioventus Inc. | 372.51 Million USD | 98.328% |
| Venus Concept Inc. | 74.3 Million USD | 91.617% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 161.177% |
| LivaNova PLC | 62.53 Million USD | 90.039% |
| 908 Devices Inc. | -115.09 Million USD | 105.412% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 98.058% |
| Nemaura Medical Inc. | 9.92 Million USD | 37.239% |
| NeuroPace, Inc. | 54.33 Million USD | 88.536% |
| LENSAR, Inc. | -18.31 Million USD | 134.016% |
| Apyx Medical Corporation | -5.15 Million USD | 220.928% |
| Cutera, Inc. | 288.3 Million USD | 97.839% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 17.112% |
| BioSig Technologies, Inc. | 262 Thousand USD | -2277.481% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 114.212% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 167.714% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.557% |
| Axonics, Inc. | -77.19 Million USD | 108.069% |
| Outset Medical, Inc. | 67.67 Million USD | 90.796% |
| IRIDEX Corporation | -4.28 Million USD | 245.266% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 103.499% |
| IRadimed Corporation | -47.71 Million USD | 113.053% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 305.849% |
| INVO Bioscience, Inc. | 8.45 Million USD | 26.294% |
| Telesis Bio, Inc. | 32.63 Million USD | 80.913% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 348.948% |
| Varex Imaging Corporation | 316.9 Million USD | 98.034% |
| Quipt Home Medical Corp. | 81.73 Million USD | 92.379% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 323.904% |
| Pulmonx Corporation | -42.36 Million USD | 114.705% |
| Dynatronics Corporation | 6.2 Million USD | -0.402% |
| Modular Medical, Inc. | -8.04 Million USD | 177.456% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 244.962% |
| Semler Scientific, Inc. | -57.13 Million USD | 110.903% |
| InMode Ltd. | -135.39 Million USD | 104.601% |
| Bruker Corporation | 891.3 Million USD | 99.301% |
| Cytosorbents Corporation | 4.18 Million USD | -48.947% |
| DexCom, Inc. | 2.02 Billion USD | 99.693% |
| Align Technology, Inc. | -840.47 Million USD | 100.741% |
| Viveve Medical, Inc. | -13.81 Million USD | 145.095% |
| ZimVie Inc. | 450.41 Million USD | 98.617% |
| Movano Inc. | -5.86 Million USD | 206.188% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 104.633% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 1181.861% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -213.939% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 98.254% |
| Profound Medical Corp. | -18.17 Million USD | 134.266% |
| Insulet Corporation | 798.1 Million USD | 99.22% |
| enVVeno Medical Corporation | -2.21 Million USD | 380.839% |
| Surmodics, Inc. | -12.01 Million USD | 151.848% |
| iCAD, Inc. | -21.2 Million USD | 129.37% |
| Nuwellis, Inc. | -2.81 Million USD | 320.965% |
| Biotricity, Inc. | 23.09 Million USD | 73.026% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 93.349% |
| Aethlon Medical, Inc. | -4.5 Million USD | 238.371% |
| InspireMD, Inc. | -8.04 Million USD | 177.427% |
| PAVmed Inc. | 29.08 Million USD | 78.584% |
| BIOLASE, Inc. | 11.34 Million USD | 45.09% |
| FONAR Corporation | -14.66 Million USD | 142.474% |
| AxoGen, Inc. | 32.26 Million USD | 80.695% |
| Vivani Medical, Inc. | 42 Thousand USD | -14730.952% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 158.444% |
| Inari Medical, Inc. | -7.16 Million USD | 186.985% |
| UFP Technologies, Inc. | 40.77 Million USD | 84.723% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -102.99% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 230.551% |
| Tenon Medical, Inc. | -1.25 Million USD | 596.335% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 181.896% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 152.229% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.719% |
| Sintx Technologies, Inc. | 905 Thousand USD | -588.287% |
| NanoVibronix, Inc. | -3.27 Million USD | 290.024% |
| Quanterix Corporation | -132.95 Million USD | 104.685% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 323.904% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 127.852% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.174% |
| TransMedics Group, Inc. | 121.13 Million USD | 94.858% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 123.793% |
| NeuroMetrix, Inc. | -1.49 Million USD | 517.754% |
| Hyperfine, Inc. | -75.61 Million USD | 108.237% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 95.907% |
| Biomerica, Inc. | -3.38 Million USD | 284.018% |
| Bone Biologics Corporation | -3.02 Million USD | 305.811% |
| AVITA Medical, Inc. | -26.23 Million USD | 123.746% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 438.825% |
| Silk Road Medical, Inc | 64.42 Million USD | 90.331% |